Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-interventional, Observational Study for Multi-dimensional Assessment of Signs, Symptoms, Quality of Life and Disease Control of Long-term Treatment With Dupilumab in Patients With Atopic Dermatitis (≥6 Years)

NCT06039241 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06039241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06039241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-interventional, Observational Study for Multi-dimensional Assessment of Signs, Symptoms, Quality of Life and Disease Control of Long-term Treatment With Dupilumab in Patients With Atopic Dermatitis (≥6 Years)
Lead sponsor
Sanofi
Phase
Observational
Overall status
Active, not recruiting
Start date
March 7, 2023
Completion date
March 8, 2028
Enrollment
572 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis